Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IROA Technologies, University of Florida Announce Biomarker Collaboration

Published: Wednesday, July 02, 2014
Last Updated: Wednesday, July 02, 2014
Bookmark and Share
Company will support the University of Florida in a collaborative search for biomarkers of liver cancer and other liver diseases.

The collaboration will leverage the University of Florida’s Clinical and Translational Science Institute (CTSI) Biorepository, which contains a diverse collection of normal and diseased human tissues and may be used for IRB-approved research.  In addition, UF’s Southeast Center for Integrated Metabolomics (SECIM) will provide state-of the-art metabolic profiling using the IROA protocol as a foundation for exploring liver biochemical diversity and disease response.

Felice de Jong, CEO of IROA Technologies, stated, “We are pleased to be both a partner at SECIM where clients can send IROA samples for metabolic profiling analysis and now a collaborator within CTSI for biomarker discovery.  We are thrilled to be working with two such significant units within the University of Florida.  We feel this strength will assure a high probability of success. ”

IROA Technologies and UF will focus on analyzing and validating clinical tissue biomarkers in liver cancer and fatty liver disease, de Jong said, adding that UF will provide medical support and interpretation of results through an established expert liver disease and mass spectrometry Advisory Committee.  Beyond the initial discovery phases, the ability of CTSI and SECIM to support all levels of validation and testing will be critical to the long-term success of this endeavor.  

"The partnership with IROA Technologies and Dr. Chris Beecher will allow UF to develop novel methods for the identification of biomarkers for human disease. UF and the CTSI are now uniquely positioned to advance and translate metabolomics to improve health for millions of Americans," said David R. Nelson, M.D., an assistant vice president for research at UF and director of the UF CTSI.  "The relationship between IROA Technologies and SECIM keeps us at the cutting edge of new and powerful metabolomics technologies,” said Art Edison, Ph.D., Director of SECIM.

Financial and other terms of the agreement were not disclosed.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!